A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

NCT02536183 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Pediatric Cancer
Solid Tumors
Rhabdomyosarcoma
Ewing Sarcoma
Soft Tissue Sarcomas
Osteosarcoma
Neuroblastoma
Wilms Tumor
Hepatic Tumor
Germ Cell Tumors

Interventions

DEVICE: Magnetic resonance high intensity focused ultrasound
DRUG: Lyso-thermosensitive liposomal doxorubicin

Sponsor

AeRang Kim